Article Versions Notes

Ortega-García MB, Mesa A, Moya ELJ, Rueda B, Lopez-Ordoño G, García JÁ, Conde V, Redondo-Cerezo E, Lopez-Hidalgo JL, Jiménez G, et al. Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy. Cancers. 2020; 12(2):379. https://doi.org/10.3390/cancers12020379

Ortega-García, María Belén, Alberto Mesa, Elisa L.J. Moya, Beatriz Rueda, Gabriel Lopez-Ordoño, Javier Ángel García, Verónica Conde, Eduardo Redondo-Cerezo, Javier Luis Lopez-Hidalgo, Gema Jiménez, and et al. 2020. "Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy" Cancers 12, no. 2: 379. https://doi.org/10.3390/cancers12020379

Ortega-García, M. B., Mesa, A., Moya, E. L. J., Rueda, B., Lopez-Ordoño, G., García, J. Á., Conde, V., Redondo-Cerezo, E., Lopez-Hidalgo, J. L., Jiménez, G., Peran, M., Martínez-González, L. J., del Val, C., Zwir, I., Marchal, J. A., & García, M. Á. (2020). Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy. Cancers, 12(2), 379. https://doi.org/10.3390/cancers12020379